title: Commercial factors override science in combination addiction drug trial.
authors.forename: A
authors.initials: A
authors.lastname: Byrne
mesh_terms: D002047:Buprenorphine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D009270:Naloxone / Q000008:administration & dosage*; D009292:Narcotic Antagonists / Q000008:administration & dosage*; D058850:Opiate Substitution Treatment / Q000379:methods*; D009293:Opioid-Related Disorders / Q000534:rehabilitation*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*
chemical_list: D009292:Narcotic Antagonists; D009270:Naloxone; D002047:Buprenorphine